SHELLEE TURNER: Open Payments
NPI 1952602534 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 56 payments from 15 companies in 2025. Trend: 2023 $85 · 2024 $1,268 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $334 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| PFIZER INC. | 4 | $83 |
| Lilly USA, LLC | 4 | $81 |
| Abbott Laboratories | 3 | $68 |
| Corcept Therapeutics | 2 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Dexcom, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $32 |
Products named: Ozempic, NURTEC ODT, Wegovy, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Korlym, FARXIGA.
Industry payments across TX — which companies pay providers there.
